Fall Risk in Relation to Individual Physical Activity Exposure in Patients with Different Neurodegenerative Diseases: a Pilot Study.


Journal

Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 9 1 2019
medline: 18 12 2019
entrez: 9 1 2019
Statut: ppublish

Résumé

Falls in patients with neurodegenerative diseases (NDDs) have enormous detrimental consequences. A better understanding of the interplay between physical activity (PA) and fall risk might help to reduce fall frequency. We aimed to investigate the association between sensor-based PA and fall risk in NDDs, using "falls per individual PA exposure time" as a novel measure. Eighty-eight subjects (n = 31 degenerative ataxia (DA), n = 14 Parkinson's disease (PD), n = 12 progressive supranuclear palsy (PSP) and 31 healthy controls) were included in this pilot study. PA was recorded in free-living environments with three-axial accelerometers (activPAL™) over 7 days. Falls were prospectively assessed over 12 months. Fall incidence was calculated by (i) absolute number of falls per person years (py) and (ii) falls per exposure to individual PA. Absolute fall incidence was high in all three NDDs, with differing levels (DA, 9 falls/py; PD, 14 falls/py; PSP, 29 falls/py). Providing a more fine-grained view on fall risk, correction for individual exposure to PA revealed that measures of low walking PA were associated with higher fall incidence in all three NDDs. Additionally, higher fall incidence was associated with more sit-to-stand transfers in PD and longer walking bouts in PSP. Our results suggest that low walking PA is a risk factor for falls in DA, PD and PSP, indicating the potential benefit of increasing individual PA in these NDDs to reduce fall risk. Moreover, they show that correction for individual exposure to PA yields a more differentiated view on fall risk within and across NDDs.

Identifiants

pubmed: 30617629
doi: 10.1007/s12311-018-1002-x
pii: 10.1007/s12311-018-1002-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-348

Subventions

Organisme : Robert Bosch Stiftung
ID : 32.5.1141.0049.0
Organisme : Robert Bosch Stiftung
ID : .

Références

Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):39-43
pubmed: 11877550
Clin Biomech (Bristol, Avon). 2004 May;19(4):377-84
pubmed: 15109758
Mov Disord. 2004 Dec;19(12):1391-402
pubmed: 15452868
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):468-73
pubmed: 16543524
Br J Sports Med. 2006 Sep;40(9):779-84
pubmed: 16825270
Br J Sports Med. 2006 Dec;40(12):992-7
pubmed: 16980531
Mov Disord. 2007 Oct 15;22(13):1892-900
pubmed: 17588236
Age Ageing. 2008 Jan;37(1):45-50
pubmed: 18032400
Lancet Neurol. 2010 Jan;9(1):94-104
pubmed: 20083040
Cerebellum. 2010 Jun;9(2):232-9
pubmed: 20157791
Eur Neurol. 2013;69(1):53-7
pubmed: 23146840
Parkinsons Dis. 2013;2013:906274
pubmed: 23533953
J Aging Phys Act. 2015 Apr;23(2):187-93
pubmed: 24700259
PLoS One. 2014 May 06;9(5):e96675
pubmed: 24801889
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):628-34
pubmed: 25387729
Parkinsonism Relat Disord. 2015 Mar;21(3):236-42
pubmed: 25572498
PLoS One. 2015 Jun 09;10(6):e0129098
pubmed: 26058056
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S34-6
pubmed: 26421392
J Aging Phys Act. 2016 Jul;24(3):342-9
pubmed: 26502457
Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):307-314
pubmed: 28628488
Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059

Auteurs

Karin Srulijes (K)

Department of Clinical Gerontology, Robert-Bosch-Hospital, Auerbachstrasse 110, 72376, Stuttgart, Germany. karin.srulijes@rbk.de.
Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. karin.srulijes@rbk.de.
German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany. karin.srulijes@rbk.de.

Jochen Klenk (J)

Department of Clinical Gerontology, Robert-Bosch-Hospital, Auerbachstrasse 110, 72376, Stuttgart, Germany.
Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Michael Schwenk (M)

Department of Clinical Gerontology, Robert-Bosch-Hospital, Auerbachstrasse 110, 72376, Stuttgart, Germany.

Cornelia Schatton (C)

Department of Cognitive Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Centre for Integrative Neuroscience (CIN), Tübingen, Germany.

Lars Schwickert (L)

Department of Clinical Gerontology, Robert-Bosch-Hospital, Auerbachstrasse 110, 72376, Stuttgart, Germany.

Kristin Teubner-Liepert (K)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Miriam Meyer (M)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Srijana K C (S)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Walter Maetzler (W)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.
Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.

Clemens Becker (C)

Department of Clinical Gerontology, Robert-Bosch-Hospital, Auerbachstrasse 110, 72376, Stuttgart, Germany.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH